2021
DOI: 10.3168/jds.2021-20177
|View full text |Cite
|
Sign up to set email alerts
|

Association between antimicrobial use and antimicrobial resistance of Streptococcus uberis causing clinical mastitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0
4

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 35 publications
0
10
0
4
Order By: Relevance
“…This remarkable result will allow management staff to make informed decisions regarding animal welfare and pursue the most appropriate treatment regimens. Martins et al [28] also considered S. uberis, an organism which causes up to 17% of clinical mastitis cases in dairy cattle. In their work, they isolated colonies from dairy herds in the southeast of Brazil.…”
Section: Mycoplasmamentioning
confidence: 99%
“…This remarkable result will allow management staff to make informed decisions regarding animal welfare and pursue the most appropriate treatment regimens. Martins et al [28] also considered S. uberis, an organism which causes up to 17% of clinical mastitis cases in dairy cattle. In their work, they isolated colonies from dairy herds in the southeast of Brazil.…”
Section: Mycoplasmamentioning
confidence: 99%
“…También se ha reportado una alta sensibilidad frente a oxacilina, variando entre el 85 y 90 % 3, 4, 37, 50 . Las cefalosporinas han demostrado un elevado nivel de actividad in vitro, con porcentajes de sensibilidad cercanos al 100% 32,37,54,63 .…”
Section: Estrategias De Prevención Y Controlunclassified
“…En cuanto a las tetraciclinas se observó un aumento de la resistencia a lo largo del tiempo, posiblemente debido al extenso uso de estos antibióticos en lechería 32 . Resultados publicados entre 2010 y 2018 indican un nivel de resistencia del 10% al 40% 3,4,14,18,63 .…”
Section: Estrategias De Prevención Y Controlunclassified
“…Antibiotics have been used to treat microbial infections in humans and animals ( 1 ). However, the overuse of antibiotics has caused bacteria to exhibit different levels of resistance ( 2 ). Meanwhile, the development of new antibiotics has been quite slow ( 3 ), and new strategies are needed to improve the effectiveness of existing antibiotics to cope with emerging antibiotic resistance ( 4 ).…”
Section: Introductionmentioning
confidence: 99%